Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10,25 mg RPC1063----1件: 96 💬
20.25 mg RPC1063----3件: 13, 96, 97 💬
30.25mg RPC1063----2件: 13, 97 💬
40.5 mg RPC1063----2件: 13, 97 💬
50.5mg RPC1063----1件: 13 💬
61 mg RPC1063----2件: 13, 97 💬
71.0 mg RPC1063----1件: 97 💬
81.0mg RPC1063----1件: 13 💬
914C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration----3件: 13, 96, 97 💬
101mg RPC1063----1件: 96 💬
11RPC1063----3件: 13, 96, 97 💬
12RPC1063 (equivalent to ozanimod1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬
13RPC1063 (equivalent to ozanimod HCl)1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬
14RPC1063 equiv to ozanimod HCI1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬
15RPC1063 equiv. to ozanimod HCI1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬